Pathogenesis

  • Duncan Dartrey Adams
  • Christopher Dartrey Adams
Chapter
Part of the SpringerBriefs in Public Health book series (BRIEFSPUBLIC)

Abstract

In World War II, British fighter pilots defending England from bombing by the Nazi Luftwaffe, sometimes survived with terrible burns to the face and hands. This caused surgeons to attempt to heal them with skin grafts and led Medawar to study the fate of grafts performed between rabbits.

Keywords

Autoimmune Disease Diabetic Retinopathy Histocompatibility Antigen Antibody Molecule FOXP3 Gene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Medawar PB. The behaviour and fate of skin autografts and skin homografts in rabbits. J Anat. 1944;78:176–99.PubMedGoogle Scholar
  2. 2.
    Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature. 1953;172:603–6.PubMedCrossRefGoogle Scholar
  3. 3.
    Nossal JG, Pike B. Evidence for the clonal abortion theory of B lymphocyte tolerance. J Exp Med. 1975;141:904–17.PubMedGoogle Scholar
  4. 4.
    Adams DD. Autoimmune mechanisms. In: Davies TF, editor. Autoimmune endocrine disease. New York: Wiley; 1983. p. 1–39.Google Scholar
  5. 5.
    Adams DD, Knight JG. Principles of autoimmune disease: pathogenesis, genetics and specific immunotherapy. J Clin Lab Immunol. 2003;52:1–22.PubMedGoogle Scholar
  6. 6.
    Porter RR. The hydrolysis of rabbit globulin and antibodies with crystalline papain. Biochem J. 1959;73:119.PubMedGoogle Scholar
  7. 7.
    Mitchison NA. Passive transfer of transplantation immunity. Proc Roy Soc B. 1954;143:72–87.CrossRefGoogle Scholar
  8. 8.
    Shaw GM. Biology of human immunodeficiency viruses. In: Goldman L, Bennett JC, editors. Textbook of medicine. 21st edn. Philadelphia: Saunders; 2000. p. 1893–8.Google Scholar
  9. 9.
    Sherwin RS. Diabetes mellitus. In: Goldman L, Bennett JC, editors. Cecil textbook of medicine. 21st edn. Philadelphia: Saunders; 2000. p. 1263–85.Google Scholar
  10. 10.
    Sutherland DE, Goetz FC, Sibley RE. Recurrence of disease in pancreas transplants. Diabetes. 1989;38:85.PubMedGoogle Scholar
  11. 11.
    Klintworth GK. The eye. In: Rubin E, Farber JL, editors. Pathology. 2nd ed. Philadelphia: Lippincott; 1988. p. 1456–83.Google Scholar
  12. 12.
    Adams DD. Autoimmune destruction of pericytes as the cause of diabetic retinopathy. Clin Ophthalmol. 2008;2:295–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Sakaguchi S, Takahashi T, Nishizuka Y. Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Replacement of Lyt-1 cells in normal female mice for the prevention of oophoritis. J Exp Med. 1982;156:1577–86.PubMedCrossRefGoogle Scholar
  14. 14.
    Penhale WJ, Irvine WJ, Inglis JR, Farmer A. Thyroiditis in T cell-depleted rats: suppression of the autoallergic response by re-constitution with normal lymphoid cells. Clin Exp Immunol. 1976;25:6–16.PubMedGoogle Scholar
  15. 15.
    Paul WE editor. Fundamental immunology. 4th edn. Philadelphia: Lippincott-Raven; 1999. p. 605–650.Google Scholar
  16. 16.
    Natchtigal D, Zan-Bar I, Feldman N. The role of specific suppressor T cells in immune tolerance. Transplant Rev. 1975;26:87–105.Google Scholar
  17. 17.
    Allison AC, Denman AM, Barnes AD. Hypothesis. Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet. 1971;2:135–40.PubMedCrossRefGoogle Scholar
  18. 18.
    Knight JG, Adams DD. Failure of transferred thymus cells to suppress or prevent autoantibody production in NZB and NZB × NZW mice. J Clin Lab Immunol. 1978;1:151–8.Google Scholar
  19. 19.
    Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;160:1151–64.Google Scholar
  20. 20.
    Shevack EM. Certified professionals: CD4+CD25+ suppressor T cells. J Exp Med. 2001;193:41–6.CrossRefGoogle Scholar
  21. 21.
    Lopes JE, Torgerson TR, Schubert LA, Anover SD, Ocheltree EL, Ochs HD, Ziegler SF. Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor. J Immunol. 2006;177:3133–42.PubMedGoogle Scholar
  22. 22.
    Bennett CL, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutation of FOXP3. Nat Genet. 2001;7:20–1.CrossRefGoogle Scholar
  23. 23.
    Sakaguchi S. Naturally-arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531–62.PubMedCrossRefGoogle Scholar
  24. 24.
    Shevach EM. Organ-specfic autoimmunity. In: Paul WE, editor. Fundamental immunology. 4th edn. Philadelphia: Lippincott-Raven; 1999. p. 1089–125.Google Scholar
  25. 25.
    Watson JD, Crick FH. Molecular structure of nucleic acids. Nature. 1953;171:737–8.PubMedCrossRefGoogle Scholar
  26. 26.
    Jerne NK. The natural selection theory of antibody formation. Proc Nat Acad Sci USA. 1955;41:849–3.PubMedCrossRefGoogle Scholar
  27. 27.
    Burnet FM. The clonal selection theory of acquired immunity. London: Cambridge University Press; 1959.Google Scholar
  28. 28.
    Burnet FM. Autoimmune disease. BMJ. 1959; 2: 645–50 and 720–5.Google Scholar
  29. 29.
    Knight J, Laing P, Knight A, Adams DD. Ling N R. Thyroid-stimulating autoantibodies usually contain only λ light chains: evidence for the forbidden clone theory. J Clin Endocrinol Metab. 1986;62:342–7.PubMedCrossRefGoogle Scholar
  30. 30.
    Pinchera A, Ingbar SH, McKenzie JM, Fenzi GF, editors. Thyroid autoimmunity. New York: Plenum Press; 1987.Google Scholar
  31. 31.
    Adams DD, Knight A, Knight JG, Laing P. Graves’ disease; a paradigm for autoimmunity. In: Pinchera A, Ingbar SH, McKenzie JM, Fenzi GF, editors. Thyroid autoimmunity. New York: Plenum; 1987. p l–10.Google Scholar
  32. 32.
    Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science. 1985;228:1315–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Scott JK, Smith GP. Searching for peptide ligands with an epitope library. Science. 1990;249:386–90.PubMedCrossRefGoogle Scholar
  34. 34.
    Adams DD. Thyroid-stimulating autoantibodies. Vitam Horm. 1980;38:119–203.PubMedCrossRefGoogle Scholar
  35. 35.
    Lindstrom J, Shelton D, Fujii Y. Myasthenia gravis. Adv Immunol. 1988;42:233–84.PubMedCrossRefGoogle Scholar
  36. 36.
    Saus J, Wieslander CM, Langeveld JPM, Quinones S, Hudson BG. Identification of the Goodpasture antigen as the alpha 3 (IV) chain of collagen IV. J Biol Chem. 1988;263:13374–80.PubMedGoogle Scholar
  37. 37.
    Roitt IM, Doniach D, Shapland C. Autoimmune phenomena in relation to gastric mucosa in human disease. In: Grabar P, Miescher PA, editors Immunopathology. IVth International Symposium. Schwabe: Basel; 1965. P. 314–324.Google Scholar
  38. 38.
    Adams DD. Systemic lupus erythaematosus: a simple concept of the pathogenesis and its genetic basis. In: Dawkins RL, Christiansen FT, Zilko PJ, editors. Immunogenetics in rheumatology. Amsterdam: Excerpta Medica; 1982. p. 242–3.Google Scholar
  39. 39.
    Boey ML, Colaco CB, Gharadi AE, Elkon KB, Loizou S, Hughes GRV. Thrombosus in systemic lupus erythaematosus: striking association with the presence of circulating lupus anticoagulant. BMJ. 1983;287:1021–3.PubMedCrossRefGoogle Scholar
  40. 40.
    Exner T. Lupus anticoagulant. Today’s. Life Sci. 1989;1:40–6.Google Scholar
  41. 41.
    Davis AE, Ziegler JB, Gelfand EW, Rosen FS, Alpers CA. Hetereogeneity of nephritic factor and its identification as an immunoglobulin. Proc Natl Acad Sci USA. 1977;74:3980–3.PubMedCrossRefGoogle Scholar
  42. 42.
    Kaplan ME. Autoimmune haemolytic disease due to warm-reacting antibodies. In: Wyngaarden JB, Smith LM, editors. Textbook of Medicine. 17th ed. Saunders: Philadelphia; 1985. p. 908–10.Google Scholar
  43. 43.
    Marcus AJ. Idiopathic thrombocytopenic purpura. In: Wyngaarden JB, Smith LM, editors. Textbook of medicine. 17th ed. Saunders: Philadelphia; 1985. p. 1033–4.Google Scholar
  44. 44.
    Wilson C, Ebringer A, Ahmadi K, Wrigglesworth J, Tiwana H, Fielder M, Binder A, Ettelaie C, Cunningham P, Joannou C, Bansal S. Shared amino acid sequences between major histocompatibility complex class II glycoproteins, type XI collagen and proteus mirabilis in rheumatoid arthritis. Ann Rheum Dis. 1995;54:216–20.PubMedCrossRefGoogle Scholar
  45. 45.
    Menard HA, El-Amine M. The calpain-calpastatin system in rheumatoid arthritis. Immunol Today. 1996;17:545–7.PubMedCrossRefGoogle Scholar
  46. 46.
    Knight JG. Dopamine receptor-stimulating autoantibodies: a possible cause of schizophrenia. Lancet 1982;ii:1073–6.Google Scholar
  47. 47.
    Knight JG, Knight A, Pert CB. Is schizophrenia a virally-triggered anti-receptor autoimmune disease? In: Helmchen H, Henn FA, ediors. Biological Perspectives of Schizophrenia. New York: Wiley; 1987. p.107–27.Google Scholar
  48. 48.
    Potter SR, Bienenstock J, Goldstein S, Buchanan WW. Fibroblast growth factors in scleroderma. J Rheumatol. 1985;12:1129–35.PubMedGoogle Scholar
  49. 49.
    Xu W, Leroy EC, Smith EA. Fibronectin release by systemic sclerosis and normal dermal fibroblasts in response to TGF-β. J Rheumatol. 1991;18:241-246.Google Scholar
  50. 50.
    Gilliland BC. Systemic sclerosis. In: Braunwald E, Fauci AS, Kasper DL, Hauser S, Longo Di, Jameson JL. (eds.) Harrison’s Principles of Internal Medicine. 15th ed. New York: McGraw-Hill; 2001;1937–1946.Google Scholar
  51. 51.
    Fallon MD, Schwamm HA. Paget’s disease of bone. Pathology Annual 1989;24:Part 1:115–159Google Scholar
  52. 52.
    Williams DG, Peters DK. Glomerulonephritis and renal manifestations of systemic disease. In: Weatheral DJ, Ledingham JGG, Warrell DA, editors. Oxford textbook of medicine. 2nd ed. University Press: Oxford; 1987. p. 36–55.Google Scholar
  53. 53.
    Bisno AL. Rheumatic fever. In: Wyngaarden JB, Smith LM, editors. Textbook of Medicine. 17th ed. Saunders: Philadelphia; 1985. p. 1527–33.Google Scholar
  54. 54.
    Tagg JR, McGiven AR, Guthrie DA. Heart-reactive antibodies in rheumatic fever. Med J Australia. 1972;1:621–624.Google Scholar
  55. 55.
    Dienstag JL, Isselbacher KJ. Autoimmune hepatitis. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison’s principles of internal medicine. 15th ed. McGraw-Hill: New York; 2001. p. 1750–2.Google Scholar
  56. 56.
    Williams GH, Dluhy RG. Disorders of the adrenal cortex. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison’s principles of internal medicine. 15th ed. McGraw-Hill: New York; 2001. p. 2084–105.Google Scholar
  57. 57.
    Rubin E, Faber J. Primary biliary cirrhosis. In: Rubin E, Farber JL, editors. Pathology. 2nd ed. Lippincott: Philadelphia; 1994. p. 740–743.Google Scholar
  58. 58.
    Hauser SL, Goodkin GE. Multiple sclerosis and other demyelinating diseases. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, editors. Harrison’s principles of internal medicine. 15th ed. McGraw-Hill: New York; 2001. p. 2452–2461.Google Scholar
  59. 59.
    Banker BQ, Engel AG. The polymyosytis and dermatomyositis syndromes. In: Engel AC, Banker BQ, editors. Myology: basic and clinical. McCraw Hill: New York; 1986. p. 1385–1422.Google Scholar

Copyright information

© The Author(s) 2013

Authors and Affiliations

  • Duncan Dartrey Adams
    • 1
  • Christopher Dartrey Adams
    • 2
  1. 1.Faculty of MedicineUniversity of OtagoDunedinNew Zealand
  2. 2.Analogue Digital InstrumentsDunedinNew Zealand

Personalised recommendations